Calle JosE Isbert, 2
Pozuelo de AlarcOn
Madrid 28223
Spain
34 91 021 30 00
https://www.rovi.es
Sector(es): Healthcare
Industria: Biotechnology
Empleados a tiempo completo: 2,137
Nombre | Título | Pagar | Ejecutado | Año de nacimiento |
---|---|---|---|---|
Mr. Juan Lopez-Belmonte Encina | Chairman & CEO | 1.17M | N/D | N/D |
Mr. Ivan Lopez-Belmonte Encina | Second Deputy Chairman & GM of Commercial and Development | 472k | N/D | N/D |
Mr. Javier Lopez-Belmonte Encina | First Deputy Chairman, GM of Industrial Operations & CFO | 474k | N/D | N/D |
Marta Campos Martínez | Head of Investor Relations | N/D | N/D | N/D |
Ms. Mercedes Benítez del Castillo Sánchez | Legal Department Manager | N/D | N/D | N/D |
Ms. Beatriz Ávila Alcalde | Sales Manager | N/D | N/D | N/D |
Ms. Rosario Perucha Pérez | Marketing Manager | N/D | N/D | N/D |
Mr. Francisco Javier Angulo García | Human Resources Manager | N/D | N/D | N/D |
Mr. Gabriel Nunez Fernandez | Secretary | N/D | N/D | N/D |
Laboratorios Farmaceuticos Rovi, S.A. engages in the research, development, manufacture, and marketing of pharmaceutical products in Spain and internationally. The company provides products for cardiology, osteoarticular/women's health, anesthesia /pain, diagnostic imaging contrast agents, central nervous system, urology, endocrinology, respiratory, and primary healthcare areas. Its principal products include Ameride, Bertanel, Bluxam, Enoxaparin Rovi, Calcium Vitamine D3 Rovi, Exxiv, Prinvil, Rhodogil, Glufan, Hibor, Hirobriz Breezhaler, Neparvis, Medicebran, Medikinet, Mysimba, Orvatez, Tryptizol, Ulunar Breezhaler, and Volutsa; and hospital products, such as Iomeron and Iopamiro, Multihance and Y Prohance, Sonovue, Empowercta+, Empowermr, and CT Express, Fibrilin, and Sodium Heparin Rovi. It also provides contract-manufacturing services to other companies for a range of pharmaceutical forms, including prefilled syringes, vials, suppositories, tablets, and sachets. Laboratorios Farmaceuticos Rovi, S.A. was incorporated in 1946 and is headquartered in Madrid, Spain. Laboratorios Farmaceúticos Rovi, S.A. is a subsidiary of Norbel Inversiones, S.L.
La calificación ISS Governance QuickScore de Laboratorios Farmaceuticos Rovi, S.A. a partir del 1 de octubre de 2024 es 2. Las puntuaciones principales son Auditoría: 8; Junta: 4; Derechos del accionista: 6; Compensación: 1.